Kim; Bo Gyou

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Bo Gyou.The latest application filed is for "combination therapy using dual inhibitor of c-met and egfr and igf-1r inhibitor".

Company Profile

2.13.15

Kim; Bo Gyou - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biomarker PNCK for predicting effect of a dual-targeting agent Grant 10,578,621 - Lee , et al.	2020-03-03
Polypeptide, anti-VEGF antibody, and anti-c-Met/anti-VEGF bispecific antibodies comprising the same Grant 10,246,507 - Lee , et al.	2019-04-02
Biomarker Hsp90 for predicting effect of a c-Met inhibitor Grant 9,956,244 - Lee , et al. May 1, 2	2018-05-01
Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor Grant 9,943,596 - Lee , et al. April 17, 2	2018-04-17
Biomarker TFF1 for predicting effect of C-MET inhibitor Grant 9,850,537 - Kim , et al. December 26, 2	2017-12-26
Anti-c-Met/anti-Ang2 bispecific antibody Grant 9,808,507 - Oh , et al. November 7, 2	2017-11-07
Combination therapy for the treatment of cancer using an anti-C-met antibody Grant 9,567,641 - Kim , et al. February 14, 2	2017-02-14
Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker Grant 9,535,055 - Kim , et al. January 3, 2	2017-01-03
Combination Therapy Using Dual Inhibitor Of C-met And Egfr And Igf-1r Inhibitor App 20160144028 - Lee; Jimin ; et al.	2016-05-26
Polypeptide, Anti-vegf Antibody, And Anti-c-met/anti-vegf Bispecific Antibodies Comprising The Same App 20160090427 - Lee; Seung Hyun ; et al.	2016-03-31
Anti-c-met/anti-ang2 Bispecific Antibody App 20160053025 - Oh; Seungja ; et al.	2016-02-25
Biomarker Pnck For Predicting Effect Of A Dual-targeting Agent App 20160033518 - Lee; Ji Min ; et al.	2016-02-04
Biomarker Hsp90 For Predicting Effect Of A C-met Inhibitor App 20160030559 - LEE; Ji Min ; et al.	2016-02-04
Method of treating solid cancers using anti-c-Met antibody and sorafenib combination therapy Grant 9,233,155 - Kim , et al. January 12, 2	2016-01-12
Use of LRIG1 as a biomarker for identifying a subject for application of anti-c-Met antibodies Grant 9,213,032 - Lee , et al. December 15, 2	2015-12-15
Use of Cbl as biomarker for identifying subject suitable for treatment with anti-c-Met antibody Grant 9,213,031 - Lee , et al. December 15, 2	2015-12-15
Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy Grant 9,192,666 - Kim , et al. November 24, 2	2015-11-24
Biomarker Tff1 For Predicting Effect Of C-met Inhibitor App 20150212077 - Kim; Bo Gyou ; et al.	2015-07-30
Combination Therapy For The Treatment Of Cancer Using An Anti-c-met Antibody App 20150010575 - KIM; Bo Gyou ; et al.	2015-01-08
Method Of Combination Therapy Using Anti-c-met Antibody And Fgfr Inhibitor App 20140308284 - KIM; BO GYOU ; et al.	2014-10-16
Method Of Combination Therapy Using Anti-c-met Antibody And Sorafenib App 20140302030 - KIM; BO GYOU ; et al.	2014-10-09
Marker For Determing Effects Of Anti-c-met Antibody And Method Of Determing Effects Of Anti-c-met Antibody Using The Marker App 20140296097 - KIM; BO GYOU ; et al.	2014-10-02
Genes Inducing Agonistic Effects By Anti-c-met Antibody Treatment And Drug Screening Method Using The Genes App 20140200156 - KIM; Bo-gyou ; et al.	2014-07-17
Use Of Cbl As Biomarker For Identifying Subject Suitable For Treatment With Anti-c-met Antibody App 20140105901 - LEE; Ji Min ; et al.	2014-04-17
Use Of Lrig1 As A Biomarker For Identifying A Subject For Application Of Anti-c-met Antibodies App 20140105902 - LEE; Ji Min ; et al.	2014-04-17
Anti c-Met antibody and uses thereof Grant 8,501,917 - Kim , et al. August 6, 2	2013-08-06
Anti C-met Antibody And Uses Thereof App 20130129731 - KIM; Bo-gyou ; et al.	2013-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.